Blog Layout

How Liquid Biopsy Holds Promise for Early Detection of Breast Cancer with Marty Keiser & Liz Cormier-May, Mammogen, Inc.

Oct 08, 2021

"Woman-led Mammogen Inc. is looking for breast cancers in a whole new way: using liquid biopsy to detect cancers far earlier, for more women, and with greater accuracy than traditional mammograms. They're also passionate about building a community to support women well beyond their initial diagnosis. A special look at the promising future for earlier breast cancer detection, in recognition of Breast Cancer Awareness Month!"

11 Jan, 2023
Elizabeth Cormier-May, CEO of Mammogen, Inc., and Dragonfly Data Ventures, Partner and CCO of IV BioHoldings, joins SGH Corp. board of directors to provide expertise and strategy to the Company’s medical arm
23 Jan, 2022
LONDON, Jan. 19, 2022 /PRNewswire/ -- Liz Cormier-May of Mammogen was named Biotechnology CEO of the Year – USA in the 2021 Global Corporate Excellence Awards.
11 Jan, 2022
Partnership between female-led women’s healthcare companies will give away 50 pairs of Brilliantly Warm wearable bra inserts - the world’s first-ever wearable designed specifically for women after reconstructive surgery - to the breast cancer community
More posts
Share by: